BioCentury
ARTICLE | Company News

Visudyne reimbursement expanded

October 19, 2001 7:00 AM UTC

QLT (QLTI; TSE:QLT) and partner Novartis (NVS; SWX:NOVN) said that reimbursement in the U.S. for their Visudyne verteporfin photodynamic therapy will be expanded to include patients with occult only s...